Trends and Impacts of Advanced Therapy on Chronic Opioid Use in Asian Patients with Inflammatory Bowel Disease
Inflammatory Bowel Diseases · 2026
DOI: 10.1093/ibd/izaf221 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2026. Verfasst von Yu Kyung Jun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea. Hauptthemen laut MEDLINE: Analgesics, Opioid, Opioid-Related Disorders, Colitis, Ulcerative, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Seoul National University Bundang Hospital Research Fund.
Abstract (Originalsprache)
Objective
Opioid use in Asian patients with inflammatory bowel disease (IBD) remains poorly understood. This study aimed to investigate the trends in chronic opioid use, associated clinical factors, and effects of advanced therapy (AT) on opioid use in Korean patients with IBD.
Methods
This nationwide cohort study used administrative claims data from the Korean National Health Insurance Service (2010-2022). Chronic opioid use was defined as opioid use for ≥90 days or ≥3 prescriptions within a calendar year. Logistic regression was used to identify clinical factors associated with chronic opioid use. The impact of AT on opioid use was analyzed through pre- and post-initiation comparisons using McNemar’s tests, generalized estimating equations (GEE), and a linear mixed model.
Results
Chronic opioid use increased over the study period, with a higher prevalence in Crohn’s disease (CD) than in ulcerative colitis (UC) (CD: 1.38%, UC: 0.53% in 2010; CD: 5.38%, UC: 1.98% in 2020). Among 49 548 newly diagnosed IBD patients, female sex, steroid and immunomodulator treatments, hospitalizations, emergency room visits, and mental disorders were positively associated with chronic opioid use in CD and UC. AT was positively associated with chronic opioid use in UC (odds ratio [OR] 1.627, P < .0001) but negatively associated with CD (OR 0.786, P = .0013). In CD, AT significantly reduced opioid users (McNemar’s test: P < .0001; GEE: OR 0.478, P < .0001) and average daily doses (mean difference −15.8 morphine milligram equivalents, P = .0073).
Conclusion
Chronic opioid use has increased over the past decade among Korean patients with IBD, particularly among those with CD. AT is crucial for reducing opioid use in patients with CD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
- Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
- Medical Research Collaborating Center, Seoul National University Bundang Hospital, Seongnam, South Korea.
ORCID-Profile: Yu Kyung Jun, Eunjeong Ji, Yonghoon Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Hyuk Yoon
Förderung
- Seoul National University Bundang Hospital Research Fund
Zitieren
APA
Jun, Y. K., Ji, E., Choi, Y., Shin, C. M., Park, Y. S., Kim, N., Lee, D. H., & Yoon, H. (2026). Trends and Impacts of Advanced Therapy on Chronic Opioid Use in Asian Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf221
Vancouver
Jun YK, Ji E, Choi Y, Shin CM, Park YS, Kim N, et al. Trends and Impacts of Advanced Therapy on Chronic Opioid Use in Asian Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 2026. doi:10.1093/ibd/izaf221
BibTeX
@article{Jun2026,
author = {Jun, Yu Kyung and Ji, Eunjeong and Choi, Yonghoon and Shin, Cheol Min and Park, Young Soo and Kim, Nayoung and Lee, Dong Ho and Yoon, Hyuk},
title = {Trends and Impacts of Advanced Therapy on Chronic Opioid Use in Asian Patients with Inflammatory Bowel Disease},
journal = {Inflammatory Bowel Diseases},
year = {2026},
doi = {10.1093/ibd/izaf221}
}
EUVIMED